Synergistic effect between two bacteriocin-like inhibitory substances produced by lactobacilli strains with inhibitory activity for Streptococcus agalactiae

Current Microbiology

Volumn 64, Issue 4, 2012, Pages 349-356

  Ruíz, Francisco O ^a   Gerbaldo, Gisela ^a   García, María J ^a   Giordano, Walter ^a   Pascual, Liliana ^a   Barberis, Isabel L ^a  

^a DEPARTAMENTO DE QUÍMICA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIOCIN LIKE INHIBITORY SUBSTANCE; CEFALOTIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; OXACILLIN; PENICILLIN G; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CHECKERBOARD ASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FRACTIONAL INHIBITORY CONCENTRATION; GROWTH INHIBITION; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS AGALACTIAE;

ANTI-BACTERIAL AGENTS; BACTERIOCINS; CLUSTER ANALYSIS; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG SYNERGISM; FEMALE; HUMANS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREGNANCY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 84860258359     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-011-0077-0     Document Type: Article

References (39)

1. Barberis IL, Albesa I (1994) Assay in vivo with microcin producer Pseudomonas. Biomed Lett 49:13-19
2. Barberis L, Pajaro M, Godino S, Pascual M (2002) In vitro inhibition of Gardnerella vaginalis growth by bacteriocin produced by Lactobacillus strains. Rev UNRC 22:63-70
3. Barcia Hernandez E, Negro lavarez S (2002) Fundamentos de las interacciones farmacodinámicas (I). Anal Real Acad Farm 68(2):126-172
4. Bauer AW, Kirby MM, Sherris JC, Tuurck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493-496
5. Bergeyos Manual of Determinative Bacteriology (1994) Group 4 pp 71-174; Group 5 pp 175-289; Group 17 pp 527-558. In: Holt JG (ed), 9th edn. Williams & Wilkins, Baltimore
6. Bolaños M, Cañas A, Santana O, Perez-Arellano J, de Miguel L, Martin-Sanchez A (2001) Invasive group B streptococcal disease in non-pregnant adults. Eur J Clin Microbiol Infect Dis 20: 837-839 (Pubitemid 34020467)
7. Centers for Disease Control and Prevention (CDC) (2002) Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR 51:1-18
8. Cepeda C, Santos Y (2000) Rapid and low-level toxic PCR-based method for routine identification of Flavobacterium psychrophilum. Int Microbiol 3:235-238
9. Chohan L, Hollier L, Bishop K, Kilpatrick C (2006) Patterns of antibiotic resistance among group B Streptococcus isolates: 2001-2004. Infect Dis Obstet Gynecol 57492:1-4
10. De Man JC, Rogosa M, Sharpe ME (1960) A medium for the cultivation of lactobacilli. J Appl Bacteriol 23:130-135
11. Eduards MS, Baker JC (2001) GroupBstreptococcal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and the newborn infant.WBSaunders Co., Philadelphia, pp 1091-1156
12. García SD, Eiseth MC, Lazzo MJ, Copolillo E, Barata AD, de Torres R, Vay CA, Famiglietti AM (2003) Group B Streptococcus carriers among pregnant women. Rev Argent Microbiol 35(4): 183-187 (Pubitemid 38084001)
13. Heelan JS, Hasenbein ME, McAdam AJ (2004) Resistance of group B Streptococcus selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol 42(3):1263-1264 (Pubitemid 38332861)
14. Hensler M, Liu G, Sobzak S, Benirschke K, Nizet V, Heldt G (2005) Virulence role of Group B Streptococcus b hemolysin/ cytolysin in a neonatal rabbit model of early-onset pulmonary infection. J Infect Dis 191:1287-1291
15. Lane DJ (1991) 16S/23S rRNA sequencing. In: Stackebrant E, Goodfellow M (eds) Nucleic acid techniques in bacterial systematic. Wiley, New York, pp 115-175
16. Lindahl G, Stalhammar-Carlemalm M, Areschoug T (2005) Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev 18(1):102-127 (Pubitemid 40170663)
17. Lopardo H (2007) Antimicrobial resistance in b-hemolytic streptococci in Argentina. In: Mendez-Vilas A (ed) Communicating current research and educational topics and trends in applied microbiology, pp 794-798
18. Pineiro M, Staton C (2007) Probiotic bacteria: legislative framework requirements to evidence basis. J Nutr 137:850S-853S (Pubitemid 46397529)
19. Melancon D, Grenier D (2003) Production and properties of bacteriocin-like inhibitory substances from the swine pathogens Streptococcus suis serotype 2. Appl Environ Microbiol 69(8): 4482-4488 (Pubitemid 36992902)
20. Moore M, Schrag S, Schuchat A (2003) Effects of intrapartum antimicrobial prophylaxis for prevention of growth B streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 3:201-213 (Pubitemid 36389183)
21. Mota-Meira M, La Pointe G, Lacroix C, Lavoie M (2000) Minimum inhibitory concentrations of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob A Chemother 44:24-29 (Pubitemid 30010667)
22. Mota-Meira M, Morensy H, Lavoie M (2005) In vivo activity of mutacin B-Ny266. J Antimicrob Chemother 56:869-871 (Pubitemid 41631910)
23. National Committee for Clinical Laboratory Standards (NCCLS) (2000) Performance standards for antimicrobial disk susceptibility tests, 7th edn. Approved standard M2-A7. National Committee for Clinical Laboratory Standards, Wayne
24. Nigatu A, Ahrne S, Molin G (2000) Temperature-dependent variation in API 50 CH fermentation profiles of Lactobacillus species. Curr Microbiol 41:21-26 (Pubitemid 30395994)
25. Pascual LM (2004) Bacteriocinogenia en el género Lactobacillus: características benéficas de lactobacilos de vagina humana. Doctoral thesis, UNRC
26. Pascual LM, Daniele MB, Giordano W, Pajaro MC, Barberis IL (2008) Purification and partial characterization of novelbacteriocin L23 produced by Lactobacillus fermentum L23. Curr Microbiol 56:397-402
27. Pascual LM, Daniele MB, Pajaro C, Barberis L (2006) Lactobacillus species isolated from the vagina; identification, hydrogen peroxide production and nonoxynol-9 resistance. Contraception 73:78-81 (Pubitemid 41811194)
28. Pascual LM, Daniele MB, Ruiz F, Giordano W, Pajaro C, Barberis L (2008) Lactobacillus rhamnosus L60 a potential probiotic isolated from human vagina. J Gen Appl Microbiol 54:141-148
29. Pascual L, Ruiz F, Giordano W, Barberis L (2010) Vaginal colonization and activity of the probiotic bacterium Lactobacillus fermentum L23 in a murine model of vaginal tract infection. J Med Microbiol 59:360-364. doi:10.1099/jmm.0.012583-0
30. Petersen P, Labthavikul P, Jones C, Bradford P (2006) In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother 57:573-576 (Pubitemid 43240214)
31. Principe l, D'Arezzo S, Capone A, Petrosillo N, Visca P (2009) In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumanii. Ann Clin Microbiol Antimicrob. doi:10.1186/1476-0711-8-18
32. Quiroga M, Pegels E, Oviedo P, Pereyra E, Vergara M (2008) Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones. Argent Braz J Microbiol 39:245-250
33. Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential use of probiotics in clinical practice. Clin Microbial Rev 16:652-658
34. Rogosa M, Sharpe E (1963) Species differentiation of human vaginal lactobacilli. J Gen Microbiol 23:197-201
35. Ruiz F, Gerbaldo G, Asurmendi P, Pascual L, Giordano W, Barberis I (2009) Antimicrobial activity, inhibition of urogenital pathogens, and synergistic interactions between Lactobacillus strains. Curr Microbiol 59:497-501
36. Spaetgens R, De Bella K, Ma D, Robertson S, Mucenski M, Davies HD (2002) Perinatal antibiotic usage and changes in colonization and resistance rates of group B Streptococcus and other pathogens. Obstet Gynecol 100(3):525-533 (Pubitemid 35246140)
37. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic (2008) Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14(3):166-171
38. Stiller RJ, Padilla L, Choudhary R, Tinghitella T, Laifer S (2003) Group B streptococcal antibiotic resistance patterns in pregnant women. Conn Med 67(6):323-326 (Pubitemid 36842152)
39. Tyrrell G, Senzilet L, Spika J, Kertesz D, Alagaratnam M, Lovgren M, Talbot J (2000) Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. J Infect Dis 182:168-173 (Pubitemid 30497801)